These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
572 related items for PubMed ID: 3475452
1. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine. D'Amato RJ, Largent BL, Snowman AM, Snyder SH. J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452 [Abstract] [Full Text] [Related]
7. [3H]tetrahydrotrazodone binding. Association with serotonin binding sites. Kendall DA, Taylor DP, Enna SJ. Mol Pharmacol; 1983 May; 23(3):594-9. PubMed ID: 6865906 [Abstract] [Full Text] [Related]
8. [Characteristics of 3H-paroxetine-labeled serotonin uptake sites in rat brain]. Yoshida Y. Yakubutsu Seishin Kodo; 1988 Jun; 8(2):345-57. PubMed ID: 2975437 [Abstract] [Full Text] [Related]
9. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum. Angel I, Goldman ME, Skolnick P, Pisano JJ, Paul SM. Prog Clin Biol Res; 1985 Jun; 192():457-64. PubMed ID: 3001766 [Abstract] [Full Text] [Related]
10. 4-Iodotomoxetine: a novel ligand for serotonin uptake sites. Kung MP, Chumpradit S, Billings J, Kung H. Life Sci; 1992 Jun; 51(2):95-106. PubMed ID: 1614281 [Abstract] [Full Text] [Related]
11. Autoradiographic characterization of [3H]imipramine and [3H]citalopram binding in rat and human brain: species differences and relationships to serotonin innervation patterns. Duncan GE, Little KY, Kirkman JA, Kaldas RS, Stumpf WE, Breese GR. Brain Res; 1992 Sep 25; 591(2):181-97. PubMed ID: 1332802 [Abstract] [Full Text] [Related]
12. [The existence on the serotonin carrier of 2 independent sites for the specific binding of trazodone and imizin]. Katanasov AB, Brusov OS. Farmakol Toksikol; 1988 Sep 25; 51(6):32-5. PubMed ID: 2976683 [Abstract] [Full Text] [Related]
13. Central and peripheral cocaine receptors. Calligaro DO, Eldefrawi ME. J Pharmacol Exp Ther; 1987 Oct 25; 243(1):61-8. PubMed ID: 2822906 [Abstract] [Full Text] [Related]
14. Ascorbic acid prevents nonreceptor "specific" binding of [3H]-5-hydroxytryptamine to bovine cerebral cortex membranes. Hamblin MW, Adriaenssens PI, Ariani K, Cawthon RM, Stratford CA, Tan GL, Ciaranello RD. J Pharmacol Exp Ther; 1987 Mar 25; 240(3):701-11. PubMed ID: 3559968 [Abstract] [Full Text] [Related]
15. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes. Itzhak Y, Hiller JM, Simon EJ. Mol Pharmacol; 1985 Jan 25; 27(1):46-52. PubMed ID: 3965930 [Abstract] [Full Text] [Related]
16. Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine. Plenge P, Mellerup ET, Laursen H. Prog Neuropsychopharmacol Biol Psychiatry; 1990 Jan 25; 14(1):61-72. PubMed ID: 2137251 [Abstract] [Full Text] [Related]
17. Quantitative autoradiography of serotonin uptake sites in rat brain using [3H]cyanoimipramine. Kovachich GB, Aronson CE, Brunswick DJ, Frazer A. Brain Res; 1988 Jun 28; 454(1-2):78-88. PubMed ID: 2970277 [Abstract] [Full Text] [Related]
18. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue. Bäckström I, Bergström M, Marcusson J. Brain Res; 1989 May 08; 486(2):261-8. PubMed ID: 2525060 [Abstract] [Full Text] [Related]
19. Labeling in vivo of serotonin uptake sites in rat brain after administration of [3H]cyanoimipramine. Wolfe J, Kreider MS, Goodman C, Brunswick DJ. J Pharmacol Exp Ther; 1987 Apr 08; 241(1):196-203. PubMed ID: 3572782 [Abstract] [Full Text] [Related]
20. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors. Lyon RA, Davis KH, Titeler M. Mol Pharmacol; 1987 Feb 08; 31(2):194-9. PubMed ID: 3543649 [Abstract] [Full Text] [Related] Page: [Next] [New Search]